Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - AU
$ 2.0
-14.5 %
$ 35.3 M
Market Cap
-1.74
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
--3.59%
EBIT
Estimate
98.07%
Net Income
Estimate
--61.47%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Incannex Healthcare Limited
IXHL has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart IXHL
EBIT FORECAST
EBIT Forecast Chart IXHL
NET INCOME FORECAST
Net Income Chart IXHL